Follow-up Study on the Utility of von Willebrand Factor Levels in the Diagnosis of Cardiac Allograft Vasculopathy

Journal of Heart and Lung Transplantation

Volumn 27, Issue 7, 2008, Pages 760-766

  Martínez Dolz, Luis ^a   Almenar, Luis ^a   Reganon, Eldemiro ^a   Vila, Virtudes ^a   Chamorro, Carlos ^a   Andrés, Luis ^a   Martínez Sales, Vicenta ^a   Moro, Jose ^a   Agüero, Jaime ^a   Sánchez Lázaro, Ignacio ^a   Salvador, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; ROC CURVE; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; BIOPSY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; ULTRASONOGRAPHY, INTERVENTIONAL; VON WILLEBRAND FACTOR;

EID: 45649083844     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.04.010     Document Type: Article

References (50)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-807
2. Mehra M.R. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant 6 (2006) 1248-1256
3. Mehra M.R., Ventura H.O., Stapleton D.D., et al. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant 14 (1995) 632-639
4. Rickenbacher P.R., Pinto F.J., Lewis N.P., et al. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 92 (1995) 3445-3452
5. Kapadia S.R., Nissen S.E., and Tuzcu E.M. Impact of intravascular ultrasound in understanding transplant coronary artery disease. Curr Opin Cardiol 14 (1999) 140-150
6. Kofoed K.F., Czernin J., Johnson J., et al. Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity, and coronary vasomotion. Circulation 95 (1997) 600-606
7. Uretsky B.F., Murali S., Reddy P.S., et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76 (1987) 827-834
8. Radovancevic B., Poindexter S., Birovljev S., et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg 4 (1990) 309-312
9. Zerbe T., Uretsky B., Kormos R., et al. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant 11 suppl (1992) S104-S110
10. Lindelow B., Bergh C., Lamm C., Andersson B., and Waagstein F. Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections. Eur Heart J 20 (1999) 1326-1334
11. Stoica S.C., Cafferty F., Pauriah M., et al. Allograft vasculopathy: the cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J Heart Lung Transplant 25 (2006) 420-425
12. Reed E.F., Demetris A.J., Hammond E., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 25 (2006) 153-159
13. Cherry R., Nielsen H., Reed E., et al. Vascular (humoral) rejection in cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant 11 (1992) 24-29
14. Fredrich R., Toyoda M., Czer L.S., et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 67 (1999) 385-391
15. Cocanougher B., Ballantyne C.M., Pollack M.S., et al. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplant Proc 25 (1993) 233-236
16. Escobar A., Ventura H.O., Stapleton D.D., et al. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. Am J Cardiol 74 (1994) 1042-1046
17. Kapadia S.R., Nissen S.E., Ziada K.M., et al. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. J Am Coll Cardiol 38 (2001) 206-213
18. Holvoet P., Van Cleemput J., Collen D., and Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 20 (2000) 698-702
19. Fateh-Moghadam S., Bocksch W., Wessely R., et al. Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation 76 (2003) 1470-1474
20. Bonaros N.E., Kocher A., Dunkler D., et al. Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients. Transplantation 77 (2004) 890-897
21. Kato T., Chan M.C., Gao S.Z., et al. Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease. J Am Coll Cardiol 43 (2004) 1034-1041
22. Gao S.Z., Hunt S.A., Alderman E.L., et al. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol 29 (1997) 623-629
23. Akosah K.O., Mohanty P.K., Funai J.T., et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant 13 (1994) 1024-1038
24. Akosah K.O., McDaniel S., Hanrahan J.S., and Mohanty P.K. Dobutamine stress echocardiography early after heart transplantation predicts development of allograft coronary artery disease and outcome. J Am Coll Cardiol 31 (1998) 1607-1614
25. Spes C.H., Klauss V., Mudra H., et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. Circulation 100 (1999) 509-515
26. Carlsen J., Toft J.C., Mortensen S.A., et al. Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients. J Heart Lung Transplant 19 (2000) 873-878
27. Tse K.K., Alavi A., and Eisen H.J. Noninvasive diagnosis of cardiac transplant arteriopathy with dipyridamole thallium scintigraphy. J Nucl Med 34 (1993) 2049-2052
28. Elhendy A., Sozzi F.B., van Domburg R.T., et al. Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis. J Heart Lung Transplant 19 (2000) 360-366
29. Elhendy A., van Domburg R.T., Vantrimpont P., et al. Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging. Am J Cardiol 89 (2002) 964-968
30. Barbir M., Lazem F., Bowker T., et al. Determinants of transplant-related coronary calcium detected by ultrafast computed tomography scanning. Am J Cardiol 79 (1997) 1606-1609
31. Allen-Auerbach M., Schoder H., Johnson J., et al. Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients. J Heart Lung Transplant 18 (1999) 211-219
32. Hollenberg S.M., Klein L.W., Parrillo J.E., et al. Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation. J Heart Lung Transplant 23 (2004) 265-271
33. Mehra M.R., Benza R., Deng M.C., Russell S., and Webber S. Surrogate markers for late cardiac allograft survival. Am J Transplant 4 (2004) 1184-1191
34. Pethig K., Heublein B., Wahlers T., et al. Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia. J Heart Lung Transplant 23 (2004) 61-66
35. Labarrere C.A., Nelson D.R., Cox C.J., et al. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation. JAMA 284 (2000) 457-464
36. Pethig K., Heublein B., Kutschka I., and Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation 102 suppl (2000) III-233-III-236
37. Labarrere C.A., Lee J.B., Nelson D.R., et al. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet 360 (2002) 1462-1467
38. Raichlin E.R., McConnell J.P., Lerman A., et al. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant 26 (2007) 826-833
39. Eisenberg M.S., Chen H.J., Warshofsky M.K., et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 102 (2000) 2100-2104
40. Mehra M.R., Uber P.A., Potluri S., et al. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 94 (2004) 454-458
41. Mehra M.R., Ventura H.O., Chambers R., et al. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 26 (1995) 1537-1544
42. Kobashigawa J.A., Tobis J.M., Starling R.C., et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 45 (2005) 1532-1537
43. Tuzcu E.M., Kapadia S.R., Sachar R., et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 45 (2005) 1538-1542
44. Johnson M.R. Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant 11 suppl (1992) S124-S132
45. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
46. Valantine H., Rickenbacker P., Kemna M., et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study. Circulation 103 (2001) 2144-2152
47. Schmid C., Heemann U., and Tilney N. Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation. Transplantation 64 (1997) 222
48. Montalescot G., Ankri A., Vicaut E., et al. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 92 (1995) 31-38
49. Fuster V., Fass D.N., Kaye M.P., et al. Arteriosclerosis in normal and von Willebrand pigs: long-term prospective study and aortic transplantation study. Circ Res 51 (1982) 587-593
50. Cooke G.E., Eaton G.M., Whitby G., et al. Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol 36 (2000) 509-516